Harpoon Therapeutics, Inc. announced the appointment of Wendy Chang to Senior Vice President, Human Resources and Banmeet Anand, Ph.D., to Senior Vice President, Translational Medicine. Both Ms. Chang and Dr. Anand bring deep experience to their respective roles, enhancing strategic and scientific guidance within the organization to drive the company forward in a year of anticipated clinical advancements across Harpoon's portfolio. Ms. Chang has over 20 years of human resources experience in life sciences and an extensive background in aligning talent with organizations' overall vision and direction.

She comes to Harpoon from IDbyDNA where she served as Vice President, Head of People & Culture. She previously served as Vice President, Human Resources at Gilead Sciences and, earlier in her career, at Bio-Rad Laboratories. Dr. Anand brings more than 18 years of experience leading translational research and implementing drug discovery and development strategies for unmet medical needs across multiple therapeutic areas and clinical modalities.

Prior to joining Harpoon, Dr. Anand served as Vice President, Head of Nonclinical Development/Clinical Pharmacology at Molecular Templates. He previously served in multiple leadership and scientific roles at NantKwest, Astellas (Agensys) and Genentech.